Bendamustine, etoposide, cytarabine, melphalan and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma
Abstract
Publication Date:
2014
Iris type:
1.7 Lettera
List of contributors:
Visani, G; Stefani, P M; Capria, S; Malerba, L; Galieni, P; Gaudio, F; Specchia, G; Meloni, G; Gherlinzoni, F; Gonella, R; Gobbi, M; Santoro, A; Ferrara, F; Rocchi, M; Ocio, E M; Caballero, M D; Loscocco, F; Isidori, A
Published in: